Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenolate-Pyrazole Ligands in Oxidorhenium(V) Complexes: Catalyst Activation by Chlorido Abstraction.

Inorganic chemistry·2026
Same author

International standards and good practice guidelines in traditional, complementary and integrative medicine: a scoping review.

Frontiers in pharmacology·2026
Same author

Bioactivities of <i>Alchemilla alpina</i> L. Extract on Women's Reproductive and Metabolic Health: Antioxidant, Enzyme Inhibitory, Receptor Modulatory Properties and Potential Cytotoxic Effects.

International journal of molecular sciences·2026
Same author

Paediatric Use of Herbal Medicinal Products: New Insights in RWD Generation - A Report on the RWD Workshop 2025 in Naples.

Planta medica·2026
Same author

Synthesis of some novel sulfonamides with coumarin core. An unexpected product of the reaction.

Acta chimica Slovenica·2026
Same author

A di-nuclear μ-oxido rhenium(VI) complex: from deep purple to catalytic applications.

Dalton transactions (Cambridge, England : 2003)·2026

Related Experiment Video

Updated: Jun 1, 2026

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
08:17

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Published on: September 22, 2017

E-notopterol.

Andreas Schinkovitz, Ferdinand Belaj, Olaf Kunert

    Acta Crystallographica. Section E, Structure Reports Online
    |May 18, 2011
    PubMed
    Summary

    This study details the chemical structure of a furanocoumarin isolated from Radix seu Rhizoma Notopterygii. The crystal analysis revealed a specific weak hydrogen bond, contributing to its molecular understanding.

    Area of Science:

    • Natural Product Chemistry
    • Crystallography
    • Organic Chemistry

    Background:

    • The title compound, 4-{[(2E)-5-hydr-oxy-3,7-dimethylocta-2,6-dien-1-yl]-oxy}-7H-furo[3,2-g][1]benzopyran-7-one (C(21)H(22)O(5)), is a furanocoumarin.
    • This compound has been previously isolated from the traditional Chinese medicine, Radix seu Rhizoma Notopterygii.

    Purpose of the Study:

    • To elucidate the crystal structure of the title compound.
    • To identify intermolecular interactions within the crystal lattice.

    Main Methods:

    • Single crystal X-ray diffraction was employed to determine the molecular and crystal structure.
    • Analysis of the crystal packing and hydrogen bonding interactions.

    Main Results:

    More Related Videos

    Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity
    11:34

    Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity

    Published on: January 10, 2013

    In Vivo Imaging of Cx3cr1gfp/gfp Reporter Mice with Spectral-domain Optical Coherence Tomography and Scanning Laser Ophthalmoscopy
    06:19

    In Vivo Imaging of Cx3cr1gfp/gfp Reporter Mice with Spectral-domain Optical Coherence Tomography and Scanning Laser Ophthalmoscopy

    Published on: November 11, 2017

    Related Experiment Videos

    Last Updated: Jun 1, 2026

    Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
    08:17

    Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

    Published on: September 22, 2017

    Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity
    11:34

    Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity

    Published on: January 10, 2013

    In Vivo Imaging of Cx3cr1gfp/gfp Reporter Mice with Spectral-domain Optical Coherence Tomography and Scanning Laser Ophthalmoscopy
    06:19

    In Vivo Imaging of Cx3cr1gfp/gfp Reporter Mice with Spectral-domain Optical Coherence Tomography and Scanning Laser Ophthalmoscopy

    Published on: November 11, 2017

  • The crystal structure of the furanocoumarin was successfully determined.
  • A weak O-H⋯O hydrogen bond was identified as a significant intermolecular interaction.

    • Conclusions:

    • The crystal structure provides detailed insights into the solid-state arrangement of the furanocoumarin.
    • The identified hydrogen bond plays a role in the compound's crystal packing and stability.